Francesca Gatti

Senior Scientist at Alv B AS
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Oslo, Oslo, Norway, NO

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Norway
    • Biotechnology Research
    • 1 - 100 Employee
    • Senior Scientist
      • Dec 2021 - Present

    • Norway
    • Biotechnology
    • Project Manager
      • Jun 2019 - Nov 2021

    • Postdoc
      • Apr 2014 - May 2018

      Study of pathogenic mechanisms that trigger the development of chronic inflammation and fibrosis Study of pathogenic mechanisms that trigger the development of chronic inflammation and fibrosis

    • Norway
    • Education Administration Programs
    • 700 & Above Employee
    • PhD Student
      • Feb 2011 - Feb 2014

      Development of a new protocol for islet encapsulation in an immuno-functionalized hydrogel for islet graft immunoprotection in order to reduce the immunosuppressive regimen in islet cell transplantation. Development of a new protocol for islet encapsulation in an immuno-functionalized hydrogel for islet graft immunoprotection in order to reduce the immunosuppressive regimen in islet cell transplantation.

  • Boston Children's Hospital - Harvard Medical School
    • Boston, Massachusetts, United States
    • Research Fellow
      • Apr 2011 - Aug 2012

      Investigated the role of TIM4, a novel costimulatory molecule, in murine models of anti-islets allo- and autoimmunity Investigated the role of TIM4, a novel costimulatory molecule, in murine models of anti-islets allo- and autoimmunity

    • United States
    • Higher Education
    • 700 & Above Employee
    • Research Specialist
      • Oct 2008 - Feb 2011

      Member of the "Islet Cell Isolation Team", responsible for manufacturing human islet cells, as part of "UIC Islet Cell Transplantation Program", a NIH-funded phase III clinical trial for FDA approval of islet transplantation as cell therapy for autoimmune diabetes. Involved in two main research projects aiming at increasing islet cell mass prior to transplantation and reducing the use of immunosuppressive drugs following islet transplantation, as part of "The Chicago Diabetes Project", an international collaboration of interdisciplinary scientists. Show less

Education

  • Università del Salento
    Doctor of Philosophy (Ph.D.), Biology and Biotechnology
    2011 - 2014
  • Università degli Studi di Roma Tre
    Master's Degree, Molecular Biology
    1998 - 2006

Community

You need to have a working account to view this content. Click here to join now